HKB's Mouse Asthma Models provide pharmaceutical researchers with robust platforms for developing asthma therapeutics. Our portfolio includes OVA-induced allergic asthma, HDM-challenged models, and IL-33-driven severe asthma models representing various asthma phenotypes. These models replicate key features of asthma including airway hyperresponsiveness, eosinophilic inflammation, mucus hypersecretion, and airway remodeling.
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.